Drug Trial Radar · NCT05292586
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
Last checked: Nov 19, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,377
Actual
Start
Aug 31, 2022
Primary completion
Jun 24, 2024
Study completion Jun 24, 2024
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Mar 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma who are on medium or high dose inhaled corticosteroids.
Conditions
- Asthma
Interventions
Beclomethasone Dipropionate/Formoterol FumarateDrug
Available in pressurized inhalation solution BDP/FF 200/6 µg
Beclomethasone DipropionateDrug
Available in pressurized inhalation solution BDP 100 µg
Primary outcomes
What the sponsor says the trial is designed to measure.
- 1_Change From Baseline in FEV1 AUC0-12h Normalised by Time at Week 12Time frame: Baseline (pre-dose on Week 0) and Week 12.
Locations
91 sites in 1 country. Site status is shown where the registry gives one.
Chiesi Clinical Trial Site 840858
Mobile, Alabama
Chiesi Clinical Trial Site 840895
Chandler, Arizona
Chiesi Clinical Trial Site 840856
Encinitas, California
Chiesi Clinical Trial Site 840843
Huntington Beach, California
Chiesi Clinical Trial Site 840860
Huntington Beach, California
Chiesi Clinical Trial Site 840896
Long Beach, California
Chiesi Clinical Trial Site 840883
Los Angeles, California
Chiesi Clinical Trial Site 840810
Los Angeles, California
Chiesi Clinical Trial Site 840869
Newport Beach, California
Chiesi Clinical Trial Site 840890
North Hollywood, California
Chiesi Clinical Trial Site 840808
Northridge, California
Chiesi Clinical Trial Site 840879
Pomona, California
Chiesi Clinical Trial Site 840868
Sacramento, California
Chiesi Clinical Trial Site 840849
San Diego, California
Chiesi Clinical Trial Site 840877
San Diego, California
Chiesi Clinical Trial Site 840861
San Jose, California
Chiesi Clinical Trial Site 840881
Westminster, California
Chiesi Clinical Trial Site 840873
Colorado Springs, Colorado
Chiesi Clinical Trial Site 840800
Denver, Colorado
Chiesi Clinical Trial Site 840820
Coral Gables, Florida
Chiesi Clinical Trial Site 840841
Cutler Bay, Florida
Chiesi Clinical Trial Site 840817
Greenacres City, Florida
Chiesi Clinical Trial Site 840822
Hialeah, Florida
Chiesi Clinical Trial Site 840838
Hialeah, Florida
Chiesi Clinical Trial Site 840864
Kissimmee, Florida
Chiesi Clinical Trial Site 840814
Miami, Florida
Chiesi Clinical Trial Site 840819
Miami, Florida
Chiesi Clinical Trial Site 840875
Miami, Florida
Chiesi Clinical Trial Site 840887
Miami, Florida
Chiesi Clinical Trial Site 840821
Miami, Florida
Chiesi Clinical Trial Site 840829
Miami, Florida
Chiesi Clinical Trial Site 840828
Miami, Florida
Chiesi Clinical Trial Site 840847
Miami, Florida
Chiesi Clinical Trial Site 840818
Miami, Florida
Chiesi Clinical Trial Site 840802
Miami, Florida
Chiesi Clinical Trial Site 840835
Miami, Florida
Chiesi Clinical Trial Site 840806
Miami, Florida
Chiesi Clinical Trial Site 840855
Miami, Florida
Chiesi Clinical Trial Site 840809
Miami Gardens, Florida
Chiesi Clinical Trial Site 840863
Miami Lakes, Florida
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.